Cargando…

Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia

Predicting disease progression in chronic lymphocytic leukemia (CLL) remains challenging particularly in patients with Rai Stage 0/I disease that have an unmutated immunoglobulin heavy chain variable region (UM IGHV). Even though patients with UM IGHV have a poor prognosis and generally require earl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tschumper, Renee C., Shanafelt, Tait D., Kay, Neil E., Jelinek, Diane F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343752/ https://www.ncbi.nlm.nih.gov/pubmed/30713603 http://dx.doi.org/10.18632/oncotarget.26538

Ejemplares similares

Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression
por: Gutierrez, Albert, et al.
Publicado: (2011)

Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency
por: Pal Singh, Simar, et al.
Publicado: (2018)

Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells
por: Tschumper, Renee C., et al.
Publicado: (2022)

Dynamics of Microvesicle Generation in B Cell Chronic Lymphocytic Leukemia: Implication in Disease Progression
por: Boysen, Justin, et al.
Publicado: (2016)

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib
por: Guo, Ailin, et al.
Publicado: (2015)

Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia
por: Rout, Emily D., et al.
Publicado: (2018)

Vom Unmut zum Zorn
por: Ruhaltinger, Josef
Publicado: (2023)

Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic Leukemia
por: Maharaj, Dipnarine, et al.
Publicado: (2020)

P627: LONG-TERM OUTCOMES WITH CONTINUOUS IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF TIME TO PROGRESSION
por: Kipps, Thomas, et al.
Publicado: (2023)

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells
por: Wang, Zhiquan, et al.
Publicado: (2022)

Breiter Unmut über CERN-Ausstieg
Publicado: (2009)

Unmute the Organization Through Serious Play
por: Heldal, Frode, et al.
Publicado: (2021)

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
por: Klausen, Uffe, et al.
Publicado: (2022)

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
por: Murphy, Elizabeth J., et al.
Publicado: (2017)

Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia
por: Eagle, Gina L., et al.
Publicado: (2015)

Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia
por: Fabris, Linda, et al.
Publicado: (2020)

Multiple myeloma cell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation
por: Arendt, Bonnie K., et al.
Publicado: (2014)

Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4(+) T Cells
por: Wu, Xiaosheng, et al.
Publicado: (2010)

Epstein–Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival()
por: Ferrajoli, Alessandra, et al.
Publicado: (2015)

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
por: Kay, Neil E., et al.
Publicado: (2016)

PB1913: IGH 3’RR RECOMBINATION UNCOVERS A NON-GC IMPRINT AND C-MYC-DEPENDENT IGH REARRANGEMENT ACTIVITY IN UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA
por: Jamal, Israa Al, et al.
Publicado: (2023)

Cytotoxic T Lymphocytes to An Unmutated Tumor Rejection Antigen P1A: Normal Development but Restrained Effector Function In Vivo
por: Sarma, Supria, et al.
Publicado: (1999)

JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
por: Gangat, Naseema, et al.
Publicado: (2021)

Long non-coding RNAs in cancer progression
por: Tano, Keiko, et al.
Publicado: (2012)

Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia
por: Morlando, Mariangela, et al.
Publicado: (2015)

Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2022)

New markers for murine memory B cells that define mutated and unmutated subsets
por: Anderson, Shannon M., et al.
Publicado: (2007)

Differential Requirement for Protein Synthesis in Presynaptic Unmuting and Muting in Hippocampal Glutamate Terminals
por: Crawford, Devon C., et al.
Publicado: (2012)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias
por: Curi, Dany A., et al.
Publicado: (2015)

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
por: Sinha, Sutapa, et al.
Publicado: (2018)

High CXCR3 on Leukemic Cells Distinguishes IgHV(mut) from IgHV(unmut) in Chronic Lymphocytic Leukemia: Evidence from CD5(high) and CD5(low) Clones
por: Manukyan, Gayane, et al.
Publicado: (2020)

Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia
por: Pepe, Felice, et al.
Publicado: (2020)

Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
por: Harada, Yuichi, et al.
Publicado: (2003)

Unmuting Medical Students’ Education: Utilizing Telemedicine During the COVID-19 Pandemic and Beyond
por: Iancu, Ariella Magen, et al.
Publicado: (2020)

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
por: Bonfiglio, Silvia, et al.
Publicado: (2023)

Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation
por: Panzeri, Ilaria, et al.
Publicado: (2015)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
por: Burns, A, et al.
Publicado: (2018)

Small Non-Coding RNAs in Leukemia
por: Balatti, Veronica, et al.
Publicado: (2022)

Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing
por: Tschumper, Renee C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ecfi3sc9gqha0h4hu8kamffvu6